L-dopa in idiopathic parkinsonism.
D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D010919:Placebos; D013924:Thrombophlebitis / Q000139:chemically induced
D010919:Placebos; D004295:Dihydroxyphenylalanine